# Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

> **NCT05157971** · PHASE1 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 24 (estimated)

## Conditions studied

- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Daunorubicin Hydrochloride
- **DRUG:** Mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** Pegaspargase
- **DRUG:** Prednisone
- **DRUG:** Venetoclax
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT05157971
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-17
- **Primary completion:** 2026-05-12
- **Final completion:** 2026-05-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157971, "Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05157971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*